Targeted Clinical Research to Address Select Viral Infections-Safety, Tolerability and Pharmacokinetic Properties of CMX001 in Renal Transplant Recipients with BK Viremia.

Grant

Date/time Interval

  • September 28, 2011 - August 15, 2020
  • Total Award Amount

  • 3719125.00
  • Direct Costs

  • 2986761.00
  • Sponsor Award Id

  • HHSN272201100036C
  • Contributor

  • Gary Cutter   Investigator  
  • Richard Whitley M.D.   Principal Investigator